Lincoln Pharmaceuticals Ltd share price logo

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

BSE: 531633

Small Cap

Pharma Sector

645.80

-27.50

(-4.08%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Lincoln Pharma Stock Performance

as on April 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹642.20
    ₹678.35
    downward going graph

    0.56%

    Downside

    5.04%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹440.00
    ₹678.35
    downward going graph

    31.87%

    Downside

    5.04%

    Upside

    downward going graph

Lincoln Pharma share price movements today

Previous Close
₹673.30
Open
₹664.00
Volume
2.11L
Upper Circuit
₹807.95
Lower Circuit
₹538.65
Day's Low - High
₹642.20 - ₹678.35
52 Week Low - High
₹440.00 - ₹678.35

Lincoln Pharma Historical Returns

1 Month Return
+ 8.57 %
3 Month Return
+ 40.07 %
1 Year Return
+ 12.74 %
3 Year Return
+ 65 %
5 Year Return
+ 114.8 %

Lincoln Pharma Fundamentals

as on April 30, 2026 at 4:01 pm IST

Market Cap

₹1,293.52 Cr

Return on Equity (ROE)

13.02

PE Ratio (TTM)

14.72

Return on capital employed (ROCE)

17.42

Industry PE ratio

43.33

Beta (LTM)

0.58

P/B Ratio

0

Dividend Yield

0.33

PEG Ratio

-19.37

Quarterly Earnings Growth YOY

37.7

EPS (TTM)

41.11

Sector

Pharmaceuticals

Book Value

335.34

Lincoln Pharma Stock Valuation

as on April 30, 2026 at 4:01 pm IST

Lincoln Pharma in the last 5 years

  • Overview

  • Trends

Lowest (3.58x)

March 23, 2020

Today (14.72x)

April 30, 2026

Industry (43.33x)

April 30, 2026

Highest (19.77x)

December 9, 2024

LowHigh

Today’s Price to Earnings Ratio: 14.72x

Lincoln Pharma Technical Analysis

Track how Lincoln Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish11
Bullish3
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-1.05
Bullish
CCI (20)
475.48
Bearish
RSI (14)
43.12
Neutral
Momentum (10)
-0.85
Bullish
ADI (14)
34.69
Bearish
Ultimate Oscillator (7,14,28)
16.65
Bearish

Moving Averages

Name

Value

Action

SMA (20)
646.4
Bearish
EMA (20)
646.62
Bearish
VWMA (20)
645.99
Bearish
SMA (50)
649.16
Bearish
EMA (50)
648.15
Bearish
SMA (200)
650.43
Bearish
EMA (200)
651.31
Bearish
KAMA (200)
649.39
Bearish
DEMA (200)
645.42
Bullish

Lincoln Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lincoln Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY1,293.5222.96%0.5082623
NA1,793.45-13.45%0.72-5671,283
NA61.85-10.72%0.71746
NA1,348.31137.45%0.7142362
NA8,659.73-3.4%0.00234934

Market expectation of Lincoln Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Lincoln Pharma Stock’s Investor Sentiment and Interest

Search interest for Lincoln Pharmaceuticals Ltd Stock has increased by 290% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:290% versus previous 30 day period

Lincoln Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
135.62
155.99
146.45
142.49
147.28
161.21
146.55
168.18
154.07
163.36
166.32
Other Income
7.69
8.69
11.02
7.02
10.41
9.98
8.97
-6.88
15.27
7.23
15.15
Total Income
143.31
164.68
157.47
149.51
157.69
171.19
155.52
161.3
169.34
170.6
181.47
Expenses
114.9
124.84
116.79
124.11
124.55
132.83
122.89
141.46
130.26
137.94
142.73
Operating Profit
20.72
31.15
29.66
18.38
22.73
28.38
23.66
26.72
23.81
25.42
23.59
Operating Profit Margin %
15.28%
19.97%
20.25%
12.9%
15.43%
17.6%
16.14%
15.89%
15.45%
15.56%
14.18%
Profit Before Interest, Tax and Depreciation
28.41
39.84
40.68
25.4
33.14
38.36
32.63
19.84
39.08
32.66
38.74
Interest
0.42
0.39
0.15
0.5
0.44
0.35
0.73
0.37
0.21
0.23
0.3
Depreciation
2.55
2.58
2.81
2.69
3.22
3.22
3.22
3.23
3.48
3.62
3.72
Profit Before Tax
25.44
36.87
37.72
22.21
29.48
34.79
28.68
16.24
35.39
28.81
34.72
Tax Paid
6.43
9.21
9.67
3.62
5.8
8.45
7.92
4.67
7.71
8.83
6.12
Profit After Tax
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
19.98
28.6
Total Net profit including share of profit / Loss from associate company
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
19.98
28.6
EPS
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
14.28
Actual EPS
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
14.28
Adjusted EPS
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
14.28
Diluted EPS
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
14.28

Lincoln Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
360.61
366.15
386.49
424.19
472.12
510.31
580.55
623.23
Other Income
5.45
5.63
11.04
5.66
10
22.47
34.42
22.48
Total Income
366.07
371.78
397.53
429.85
482.12
532.78
614.97
645.71
Expenses
308.3
298.91
320.95
337.01
376.64
421.11
480.64
521.74
Operating Profit
52.31
67.24
65.54
87.18
95.48
89.2
99.91
101.49
Operating Profit Margin %
14.51%
18.36%
16.96%
20.55%
20.22%
17.48%
17.21%
16.28%
Profit Before Interest, Tax and Depreciation
57.77
72.87
76.58
92.84
105.48
111.68
134.33
123.97
Interest
5.41
4
2.02
1.56
1.45
2.03
1.46
1.88
Depreciation
6.11
6.68
7.33
7.56
8.09
9.17
10.62
12.9
Profit Before Tax
46.25
62.19
67.23
83.72
95.94
100.48
122.25
109.19
Tax Paid
11.59
13.45
15.77
21.47
26.58
27.58
28.93
26.85
Profit After Tax
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
Total Net profit including share of profit / Loss from associate company
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
EPS
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Actual EPS
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Adjusted EPS
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Diluted EPS
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11

Lincoln Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
44.8
25.04
26.63
52.84
75.42
69.27
76.13
39.26
63.22
93.02
Cash Flow from Investing Activities
-41.7
-25.49
-11.78
-18.18
-30.88
-64.22
-78.08
-36.64
-57.34
-78.95
Cash Flow from Financing Activities
-3.42
0.3
-11.41
-35.76
-37.75
-5.74
-2.56
-4.49
-5.17
-6.41
Net Cash Flow
-0.32
-0.14
3.45
-1.11
6.77
-0.7
-4.5
-1.88
0.7
7.67

Lincoln Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
48.67%
50.53%
49.8%
49.53%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
DII
0%
0%
0%
0.05%
0.04%
0%
0%
0.01%
0.01%
0.01%
0.01%
1.09%
FII
0%
2.59%
0%
3.93%
3.95%
5.19%
5.16%
5%
5.14%
4.72%
4.7%
5.19%
Public
49.58%
46.88%
46.91%
46.49%
46.24%
45.03%
45.06%
45.22%
45.07%
45.49%
45.52%
43.94%
Total Outstanding Shares
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
Total Shareholders
27,480
28,670
29,316
31,375
29,967
31,330
31,848
31,867
31,784
32,370
31,026
28,303

Mutual Funds that own Lincoln Pharma Stock

Check out the Mutual Funds with significant holdings in Lincoln Pharma .

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.04%
117

Lincoln Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Lincoln Pharma .

  • Lincoln Pharmaceuticals Ltd Earnings Results

    Lincoln Pharmaceuticals Ltd’s net profit jumped 37.7% since last year same period to ₹28.60Cr in the Q3 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 43.14% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Lincoln Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 per share on 22 May 2025 - translating a dividend yield of 0.27%.

    Read More about Dividends

Indices Featuring Lincoln Pharma Stock

Check stock indices that include Lincoln Pharma .

BSE Healthcare

₹44,614.78

-0.05 (22.48%)

Insights on Lincoln Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.70% to 5.19% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, LINCOLN stock has moved up by 40.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 155.52 Cr → 181.47 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 19.98 Cr → 28.6 Cr (in ₹), with an average increase of 30.1% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.78% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 152.8% return, outperforming this stock by 87.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 28.6% return, outperforming this stock by 15.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 45.52% to 43.94% in Mar 2026 quarter

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals, established in January 1979 as a partnership firm, was converted into a public limited company in January 1995. Primarily set up to manufacture pharmaceutical formulations such as tablets, capsules, syrups and ointments, they also obtained products from other licensed manufacturers to meet the demands of small volume parenterals. In order to increase production capacity, the company set up a modern formulation plant in Khatraj, Gujarat, and established an in-house laboratory for quality control and R&D. To fund its projects, the firm launched a public issue in February 1996, and in the year 2000, they were granted ISO 9002 and WHO certification. As a result, Lincoln Pharmaceuticals is now a leading manufacturer of quality pharmaceuticals that is continuously working to improve its operations.

Revenue: ₹166.32Cr as on December 2025 (Q3 FY26)
Net Profit: ₹28.60Cr as on December 2025 (Q3 FY26)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
OrganisationLincoln Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOKishorbhai M Shah
E-voting on sharesClick here to vote

FAQs

What is Lincoln Pharma share price today?

Lincoln Pharma share price today stands at ₹645.8 as on at the close of the market. Lincoln Pharma share today touched a day high of ₹678.35 and a low of ₹642.2.

What is the 52 week high and 52 week low range for Lincoln Pharma share?

Lincoln Pharma touched a 52 week high of ₹678.35 and a 52 week low of ₹440. Lincoln Pharma share price today i.e. is closed at ₹645.8, which is -4.80% down from its 52 week high and 46.77% up from its 52 week low.

What is Lincoln Pharma 's market capitalisation today?

Lincoln Pharma market capitalisation is ₹1,293.52 Cr as on .

How to buy Lincoln Pharma shares?

To buy Lincoln Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LINCOLN or Lincoln Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lincoln Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lincoln Pharma trading volume today?

Lincoln Pharma trading volume is 2.11L as on . This means that 2.11L shares of Lincoln Pharma were bought and sold on the stock market during today's trading session.